CATEGORIES

24.05.2017

24.05.2017 16:15

Sensoryx closes first financing round

The Swiss electronics startup Sensoryx AG announced the successfully closing of its first financing round of about 1 million Swiss Francs with private investors and members of the StartAngels. The funds will facilitate for filing for patents, funding team growth and commission the first production series of the system.

23.05.2017

23.05.2017 09:51

Fünf Startups für das Startfeld Investors Forum bestimmt

Das nächste Investors Forum, das die Ostschweizer Förderorganisation Startfeld wiederum gemeinsam mit Swiss Startup Invest durchführt, findet am 22. Juni in St. Gallen statt. Fünf Startups aus den Bereichen ICT, Digital Health und Consumer Products werden sich den Investoren präsentieren.

22.05.2017

22.05.2017 08:49

Virometix Closes Financing Round

Virometix has raised CHF 5.0 million in new equity financing. Virometix plans to use the new funds to expand its operations and progress its vaccine candidates for infectious and viral diseases and cancer to next inflections points, including the start of a phase 1 clinical study for its lead vaccine.

19.05.2017

19.05.2017 13:44

Go Beyond Investing releases 3rd investor report

Go Beyond Investing, has published its Investor Report presenting its previous financing activities. In total, CHF 17.6m has been invested. 88% of members who made at least one investment have a break even or positive portfolio return.

15.05.2017

15.05.2017 16:41

„Die Post wird meist in Schweizer Startups investieren“

Vergangene Woche hat die Post den Start eines Corporate Venturing Programms in Zusammenarbeit mit investiere bekannt gegeben. Wir haben bei Thierry Golliard, Leiter Open Innovation & Venturing bei der Post nachgefragt.

09.05.2017

09.05.2017 16:26

RaiseNow sichert sich Wachstumskapital mit PostFinance als Lead-Investor

Mit einer Minderheitsbeteiligung durch PostFinance schafft das Schweizer Startup RaiseNow die Grundlage für weiteres Wachstum. Die Investitionen fliessen in die Produktentwicklung und Markterschliessungen im In- und Ausland.

09.05.2017 12:10

NLS Pharma attracts new investors

NLS Pharma, a Swiss-based biotech group focussing on treatments for attention deficit hyperactivity disorder and other neurological disorders, has completed a Series B founding round. The company has as well completed a Phase 2 study of its lead compound.

1 2 3 4 5 6 ... 39
Show All

Events

29.06.2017 09:30 - 17:00

Swiss Diagnostics Start-Up Day 2017 University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Riggenbachstrasse 16, 4600 Olten

Show All

Trainings

29.06.2017 12:00 - 14:00

Horizon 2020 Information Event on ICT and Future & Emerging Technologies (FET) Universität Basel, Departement Mathematik und Informatik Seminarraum 00.003

Top viewed

Show All

Video

Tweets

Principal

23.06.2017
Editorial

One big innovation park

Partners

Contributors